Gilead Sciences, Inc. (GILD) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Gilead Sciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.494 Good afternoon, everyone, and welcome to Gilead's second quarter 2026 earnings conference 00:00:04.494 -- 00:00:07.797 call. My name is Rebecca, and I'll be today's host. 00:00:07.797 -- 00:00:11.800 In a moment, we'll begin our prepared remarks, followed by our Q&A session. 00:00:11.800 -- 00:00:16.823 To ask a question, please press star 1, and to withdraw your question, press star 1 00:00:16.823 -- 00:00:21.607 again. Now, I'll hand the call over to Jacquie Ross, Senior Vice President, Treasurer, 00:00:21.607 -- 00:00:24.568 and Head of Investor Relations. 00:00:24.949 -- 00:00:29.784 Thank you, Rebecca. Just after market closed today, we issued a press release with earnings 00:00:29.784 -- 00:00:35.287 results for the second quarter of 2026. The press release, slides, and supplementary 00:00:35.287 -- 00:00:40.548 data are available on the Investors section of our website at Gilead.com. 00:00:40.869 -- 00:00:44.751 The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel 00:00:44.751 -- 00:00:49.693 O'Day, our Chief Commercial and Corporate Affairs Officer, Johanna Mercier, our Chief 00:00:49.693 -- 00:00:55.177 Medical Officer, Dietmar Berger, and our Chief Financial Officer, Andrew Dickinson. 00:00:55.177 -- 00:00:59.759 After that, we'll open the call to Q&A, where the team will be joined by Cindy Peretti, 00:00:59.759 -- 00:01:05.302 the Executive Vice President of KITE. Let me remind you that we will be making forward-looking 00:01:05.302 -- 00:01:10.725 statements. Please refer to slide two regarding the risks and uncertainties relating 00:01:10.725 -- 00:01:16.367 to forward-looking statements that could cause actual results to differ materially. 00:01:16.367 -- 00:01:20.328 With that, I'll t...